Latest News

Showing 12 out of 6241 results

For Researchers

Research Integrity – why robust antibody validation is vital for drug discovery

Trusting off-the-shelf antibodies to do what the companies that sell them say they do should be a given – but it isn’t. Trusting off-the-shelf antibodies to do what the companies that sell them say they do should be a given – but it isn’t.

by Cancer Research UK | Analysis | 1 October 2026

1 October 2026

This entry is part 18 of 18 in the series Research Integrity

%postcontent%

Three researchers discussing brain scans shown on a computer screen.

Policy & Insight

Children’s and young people’s cancers – the Government must turn momentum into action

How the National Cancer plan can make a difference for children and young people affected by cancer. How the National Cancer plan can make a difference for children and young people affected by cancer.

by Steve John, Laura Danielson | Analysis | 30 September 2026

30 September 2026

This entry is part 7 of 8 in the series The National Cancer Plan for England: A closer look

%postcontent%

People crossing road with buildings visible in the background against a cloudy sky.

Health & Medicine

New report links around 33,800 cancer cases a year to deprivation in UK

People living in the UK's most deprived communities are more likely to develop cancer, with around 33,800 annual cases linked to deprivation. People living in the UK's most deprived communities are more likely to develop cancer, with around 33,800 annual cases linked to deprivation.

by Sydney Ghazarian | News | 27 September 2026

27 September 2026

UK parliament building with UK flag waving.

Policy & Insight

The National Cancer Plan promises a bold vision – now to make it a reality

Can the Government turn the National Cancer Plan's ambitions into reality, particularly in a health system undergoing significant change? Can the Government turn the National Cancer Plan's ambitions into reality, particularly in a health system undergoing significant change?

by Matt Sample, Naser Turabi | Analysis | 24 September 2026

24 September 2026

This entry is part 8 of 8 in the series The National Cancer Plan for England: A closer look

%postcontent%

Science & Technology
Policy & Insight

What’s next for liquid biopsy in cancer diagnosis and treatment?

Liquid biopsies could improve how we detect, monitor and treat cancer. But more must be done to bring their benefits to patients sooner. Liquid biopsies could improve how we detect, monitor and treat cancer. But more must be done to bring their benefits to patients sooner.

by Lizzie Owen | Analysis | 24 September 2026

24 September 2026

immunofluorescence image of human neuroblastoma

For Researchers

Latest winner in our Research is Beautiful competition

Many thanks to all the entrants of September's Research is Beautiful image competition – here is our worthy winner… Many thanks to all the entrants of September's Research is Beautiful image competition – here is our worthy winner…

by Phil Prime | In depth | 23 September 2026

23 September 2026

This entry is part 23 of 23 in the series Research is Beautiful

%postcontent%

3d,Rendering,Of,Cancer,Associated,Fibroblast,Layer,Of,Tumor,Microenvironment

For Researchers

Form follows function: decoding pancreatic cancer

Adam Bryce tells us why understanding CAF morphology could bring discovery research to bear on clinical decision making for pancreatic cancer Adam Bryce tells us why understanding CAF morphology could bring discovery research to bear on clinical decision making for pancreatic cancer

by Cancer Research UK | In depth | 22 September 2026

22 September 2026

Man in blue shirt seated with an IV in his arm next to a clinician adjusting IV drip

Policy & Insight

Tackling variation in cancer treatment: can the National Cancer Plan deliver?

We break down the National Cancer Plan’s commitments towards reducing treatment variation and consider what further action is needed. We break down the National Cancer Plan’s commitments towards reducing treatment variation and consider what further action is needed.

by Holly Norman | Analysis | 22 September 2026

22 September 2026

This entry is part 6 of 8 in the series The National Cancer Plan for England: A closer look

%postcontent%

A group of killer T cells (green and red) surrounding a cancer cell (blue, center).

Science & Technology

Beating cancer with superCARs

CAR T-cell therapy has revolutionised treatment for some blood cancers. Now scientists are working to make these cancer-fighting cells more powerful, accessible and effective for children and young people. CAR T-cell therapy has revolutionised treatment for some blood cancers. Now scientists are working to make these cancer-fighting cells more powerful, accessible and effective for children and young people.

by Nisharnthi Duggan | In depth | 18 September 2026

18 September 2026

A microscopic image of a natural killer cell, a type of immune cell important for protecting against myeloma.

Science & Technology

What can our genes tell us about preventing myeloma?

Researchers at University College London are investigating whether inherited genes can change how the body responds to smouldering myeloma. Researchers at University College London are investigating whether inherited genes can change how the body responds to smouldering myeloma.

by Elizabeth Kusimo, Tim Gunn | Analysis | 16 September 2026

16 September 2026

Charity News

New Trustees announced as Cancer Research UK strengthens research and governance leadership

Cancer Research UK announces new Trustees and future committee leadership appointments that will further strengthen the charity’s governance and scientific expertise. Cancer Research UK announces new Trustees and future committee leadership appointments that will further strengthen the charity’s governance and scientific expertise.

by Cancer Research UK | News | 15 September 2026

15 September 2026

For Researchers

Data Science: unpicking data diversity and inclusive research design

Toral Gathani and Brieuc Lehmann argue that greater clarity is needed about what inclusive research design and data diversity actually mean... Toral Gathani and Brieuc Lehmann argue that greater clarity is needed about what inclusive research design and data diversity actually mean...

by Cancer Research UK | Analysis | 15 September 2026

15 September 2026

This entry is part 6 of 6 in the series Data science

%postcontent%

Cancer News

Latest News